Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes

Inclusion Criteria

• •Quantitative study
• •* parents of patients with development anomaly and/or intellectual deficiency with no etiological diagnosis
• •* parents of patients consulting at the centres of reference in Dijon or Lyon
• •* parents of patients who have not already benefited from HTS
• •* parents of patients who are fluent in French
• •* persons without national health insurance cover
• •* inability to answer the questionnaires
• •Qualitative study
• •* persons who have provided written informed consent
• •* parents of patients with a development anomaly
• •* parents of patients consulting at the centres of reference in Dijon or Lyon
• •* parents of patients who have already benefited from HTS for diagnostic purposes
• •* persons fluent in French
• •* persons without national health insurance cover
• •* cognitive impairment making it impossible for the person to understand the aims of the study